18th Jun 2007 08:39
Cyprotex PLC18 June 2007 Press Release 18 June 2007 Cyprotex PLC ("Cyprotex" or "the Company") Cyprotex PLC (AIM: CRX), the drug discovery technology and information company,today announces that it has issued 45,828 new ordinary shares of 0.1p each ("NewOrdinary Shares") pursuant to the exercise of options. The issue of these New Ordinary shares is subject to the New Ordinary Sharesbeing admitted to trading on AIM, application for which has been made. Tradingin the New Ordinary Shares, which will rank pari passu in all respects with theexisting ordinary shares, is expected to commence on 19 June 2007. - Ends - For further information: Cyprotex PLC Robert Morrisson Atwater Tel: +44 (0) 1625 505100 Chairman & Chief Executive Officer Russell Gibbs Chief Financial Officer [email protected] www.cyprotex.com This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
CRX.L